SEOUL, July 11 (Korea Bizwire) — South Korean drug companies and biotech firms are stepping up to advance environmental, social, and governance (ESG) management following the coronavirus pandemic and concerns over global warming. SK Bioscience Co. said in its ESG report published last month for the first time since its establishment that it had generated [...]
SEOUL, May 3 (Korea Bizwire) — South Korean drug and biotechnology companies are speeding up efforts to explore new growth engines to cope with the shift of COVID-19 from pandemic to endemic. Pharmaceutical giant Celltrion Inc. aims to launch its autoimmune disease biosimilar Yuflyma in the United States this year. It also made an equity [...]
SEOUL, April 11 (Korea Bizwire) — Eight South Korean pharmaceutical companies will donate medicine, medical supplies and health supplements to Ukraine that’s been devastated by Russia’s invasion, a pharmaceutical association said Monday. The Korea Pharmaceutical and Bio-Pharma Manufacturers Association said its eight member companies offered to donate medical goods worth 3 billion won (US$2.43 million) [...]
SEOUL, Feb. 15 (Korea Bizwire) — South Korean drug companies are upping the ante to develop the country’s first homegrown COVID-19 vaccine, possibly effective against the omicron variant, which may become a game changer in fighting the yearslong pandemic. According to the latest data by the Ministry of Food and Drug Safety, a total of [...]
SEOUL, Dec. 18 (Korea Bizwire) — South Korean drugmakers have begun the process to develop COVID-19 vaccines that are effective against the new omicron variant amid concerns that the highly transmissible strain may become a dominant one soon. As the omicron variant fuels fears around the world that the pandemic could rage during the winter [...]
SEOUL, Feb. 22 (Korea Bizwire) — Major South Korean drug and biopharmaceutical companies saw their sales surge in 2020 from a year earlier despite the coronavirus pandemic, industry sources said Monday. Eleven local pharmaceutical companies in Asia’s fourth-largest economy, including Green Cross Corp. and biopharmaceutical behemoth Celltrion Inc., registered sales of more than 1 trillion [...]
SEOUL, Nov. 18 (Korea Bizwire) — A number of major South Korean pharmaceutical companies have recently signed a series of deals to manufacture vaccines and treatment drugs for the novel coronavirus, industry watchers said Wednesday. Among the front-runners is industry leader Samsung Biologics Co., which successfully inked two contract manufacturing organization (CMO) agreements this year. [...]
SEOUL, Jan. 24 (Korea Bizwire) — South Korea’s major pharmaceuticals manufacturers have set their sights on overseas markets this year as a string of their biosimilars are waiting to be approved or launched, industry sources said Friday. Celltrion Inc. said sales of its drug Remsima SC for the treatment of autoimmune diseases are set to [...]
SEOUL, Mar. 18 (Korea Bizwire) — Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said Monday. The decisions, made at annual shareholder meetings, are seen as reflecting their efforts to streamline and expand infrastructure for research and development (R&D), as well as [...]
SEOUL, Mar. 7 (Korea Bizwire) — Sales of face masks, expectorants and eyewashes in South Korea are growing fast due to the onslaught of severe fine dust, industry sources said Thursday. In recent days, South Korea has been gripped by choking fine dust — particles smaller than 10 micrometers in diameter — which can cause [...]